Friday, July 31, 2026

They Were Headed for the Moon—Then Everything Went Wrong

Apollo 13's mission faced disaster after an oxygen tank explosion, but the crew's ingenuity and teamwork led to their safe return.

Trump’s Truth Social Lost $81.3 Billion Last Year, Stock Plunges by 21%

The stock of Truth Social, the social...

2026 All-New Toyota RAV4: A Game-Changer in Hybrid SUVs?

The new Toyota RAV4 offers improved fuel efficiency, electric range, and upgraded safety features, aiming to win over Korean consumers.

Tag: botulinum toxin

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Hugel Launches Letybo in India: What This Means for the Aesthetic Market in 2026

Hugel enters the Indian market with its botulinum toxin product Letybo, targeting a 9% share in the aesthetic sector this year.

“Automation Alone Isn’t Enough”: Hugel Executive Highlights the Company’s Quality-First Manufacturing Strategy

Hugel's Geodu facility expands botulinum toxin production while prioritizing consistent quality over volume, ensuring global market compliance.

Unlocking the Secrets of Letybo: How Korea’s Leading Botulinum Toxin is Capturing 20% of China’s Market

Hugel successfully held a Letybo symposium in Chengdu, enhancing medical aesthetics knowledge among over 100 Chinese professionals.

Hugel to Showcase Core Aesthetic Portfolio at AMWC Korea as Global Expansion Gains Momentum

Hugel will showcase its aesthetic products at AMWC Korea, featuring Letybo and hosting educational programs and a networking event.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

Hugel holds ‘Letybo’ training in Indonesia to boost competitiveness and brand awareness

Hugel expands in Indonesia with a training program for Letybo, enhancing local medical professionals' skills and brand loyalty.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

INIBO Launch: How This New Botulinum Toxin is Transforming the Aesthetic Market in Peru

Inibio launched its botulinum toxin product Inibo in Peru, marking a significant entry into the Latin American medical aesthetics market.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.